M3 muscarinic acetylcholine receptor-mediated signaling is regulated by distinct mechanisms

Jiansong Luo1, John M Busillo, Jeffrey L Benovic

  • 1Department of Biochemistry and Molecular Biology, Thomas Jefferson University, BLSB 350, Philadelphia, PA 19107, USA.

Insights

G protein-coupled receptor kinase 2 (GRK2) and arrestins regulate M(3) muscarinic acetylcholine receptor (M(3) mAChR) signaling. GRK2 and arrestin-3 are key regulators of M(3) mAChR-mediated ERK activation.

Area of Science:

  • Pharmacology
  • Cellular Biology
  • Molecular Biology

Background:

  • G protein-coupled receptor kinases (GRKs) and arrestins are critical regulators of G protein-coupled receptor (GPCR) signaling.
  • Previous studies demonstrated GRK2's role in regulating the H1 histamine receptor.
  • The regulation of the M(3) muscarinic acetylcholine receptor (M(3) mAChR) by these proteins remains less understood.

Purpose of the Study:

  • To investigate the role of GRKs and arrestins in regulating M(3) mAChR-mediated signaling pathways.
  • To elucidate the specific mechanisms by which GRK2 influences M(3) mAChR function.
  • To determine the involvement of other kinases, such as casein kinase-1alpha (CK1alpha), in M(3) mAChR regulation.

Main Methods:

  • RNA interference (RNAi) was used to knockdown specific GRKs, arrestins, and CK1alpha in human embryonic kidney 293 cells.
  • Calcium mobilization assays were performed to measure M(3) mAChR activation in response to carbachol.
  • Extracellular signal-regulated kinase 1 and 2 (ERK1/2) activation was assessed following receptor stimulation.

Main Results:

  • Knockdown of GRK2, GRK3, or GRK6, but not GRK5, significantly increased carbachol-induced calcium mobilization.
  • GRK2's Galpha(q) binding domain is crucial for its inhibitory effect on M(3) mAChR-mediated calcium signaling.
  • Knockdown of arrestin-2 or arrestin-3 also enhanced calcium mobilization, while GRK2 and arrestin-3 were primary regulators of ERK activation.

Conclusions:

  • Multiple proteins dynamically regulate M(3) mAChR-mediated calcium signaling.
  • GRK2 plays a significant role in M(3) mAChR desensitization, primarily through its interaction with Galpha(q).
  • GRK2 and arrestin-3 are critical for regulating M(3) mAChR-mediated ERK activation, with GRK2 being essential for sustained ERK signaling.

Related Concept Videos

Cholinergic Receptors: Muscarinic01:25

Cholinergic Receptors: Muscarinic

The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine. 
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
Parasympathetic Signaling01:30

Parasympathetic Signaling

Parasympathetic signaling plays a crucial role in regulating various physiological processes. It involves the release of acetylcholine (ACh) by parasympathetic neurons, which can have localized and short-lived effects. The majority of ACh released is rapidly inactivated at the synapse by the enzyme acetylcholinesterase (AChE), which hydrolyzes Ach into choline and acetate. Additionally, the tissue cholinesterase deactivates any ACh diffusing into the surrounding tissues.
The effects of...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
Direct-Acting Cholinergic Agonists: Pharmacological Actions00:59

Direct-Acting Cholinergic Agonists: Pharmacological Actions

Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
Cholinergic Receptors: Nicotinic01:15

Cholinergic Receptors: Nicotinic

Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship01:29

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic antagonists are called...